The potential application of iron chelators for the treatment of neurodegenerative diseases. (Q37846107)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

review article

1 reference

title

The potential application of iron chelators for the treatment of neurodegenerative diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Robert C Hider

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Sourav Roy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Yong Min Ma

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Xiao Le Kong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

language of work or name

1 reference

22 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

239-249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Development of a novel diffusion-based method to estimate the size of the aggregated Abeta species responsible for neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Copper, iron and zinc in Alzheimer's disease senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

The fenton activity of iron(III) in the presence of deferiprone

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Oxidative stress: free radical production in neural degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Emerging beta-amyloid therapies for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Copper(II)-induced self-oligomerization of alpha-synuclein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Medicinal inorganic chemistry approaches to passivation and removal of aberrant metal ions in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Design of clinically useful iron(III)-selective chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Potentiometric, spectrophotometric and calorimetric study on iron(III) and copper(II) complexes with 1,2-dimethyl-3-hydroxy-4-pyridinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Selective iron chelation in Friedreich ataxia: biologic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Cell functions impaired by frataxin deficiency are restored by drug-mediated iron relocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Current status of metals as therapeutic targets in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Treatment of Alzheimer's disease with clioquinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

The metallobiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Neurological syndrome associated with clioquinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Potential protection from toxicity by oral iron chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Structure-activity investigation of the inhibition of 3-hydroxypyridin-4-ones on mammalian tyrosine hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

The distribution of the anti-HIV drug, 2'3'-dideoxycytidine (ddC), across the blood-brain and blood-cerebrospinal fluid barriers and the influence of organic anion transport inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Advances in the treatment of neurodegenerative disorders employing nanotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Drug delivery to the brain--realization by novel drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

PEGylated immunoliposomes directed against brain astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Macromolecular drug transport into the brain using targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Targeted delivery of proteins across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Nanoparticulate systems for brain delivery of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Glycosylated tetrahydrosalens as multifunctional molecules for Alzheimer's therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Synthesis of feralex a novel aluminum/iron chelating compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Molecular shuttle chelation: the use of ascorbate, desferrioxamine and Feralex-G in combination to remove nuclear bound aluminum

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Combating Alzheimer's disease with multifunctional molecules designed for metal passivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Glucosylated Deferiprone and Its Brain Uptake: Implications for Developing Glucosylated Hydroxypyridinone Analogues Intended to Cross the Blood−Brain Barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Lipid Solubility and Drug Penetration of the Blood Brain Barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

Transport of [125I]transferrin through the rat blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MT00087F

21 January 2018

Identifiers

DOI

10.1039/C0MT00087F

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21344071%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference